Archives
-
Nanoparticle Uptake in Human Corneal Epithelial Cells
2026-08-12
This ACS Biomaterials Science & Engineering study connects PLGA nanoparticle size and surface chemistry with uptake mechanisms in human corneal epithelial cells. Its physiologically relevant mucosal model indicates that energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated uptake, governs cellular internalization more strongly than phagocytosis across the tested formulations.
-
Recombinant Annexin V and Endothelial Thrombin Formation
2026-08-12
The 1994 Biochemical Journal study showed that recombinant Annexin V binds quiescent and stimulated human endothelial cells with similar affinity while inhibiting several phospholipid-dependent coagulation reactions. Its central contribution was to connect cell-surface binding measurements with functional suppression of factor Xa and thrombin generation, clarifying how a phosphatidylserine binding protein can regulate endothelial procoagulant activity.
-
TRPM3 Regulation by Neurosteroids and Primidone
2026-08-11
Yin and colleagues combine cryo-EM, electrophysiology, molecular dynamics, and mass spectrometry to define how pregnenolone sulfate, CIM0216, and primidone regulate the TRPM3 ion channel. The study provides a structural framework for understanding TRPM3 gain-of-function disease mutations and for developing analgesic or anticonvulsant modulators.
-
SAG Exposure Disrupts Mouse Tongue Development
2026-08-11
A 2025 Developmental Biology study shows that embryonic exposure to the Smoothened receptor agonist SAG produces reduced tongue height, abnormal muscle development, and midline clefting in mice. The findings connect excessive Hedgehog pathway activity with suppressed proliferation and reduced TGF-β2 expression, providing a pharmacological model for investigating tongue malformation mechanisms.
-
AMPK, ULK1, and Autophagy Under Energy Stress
2026-08-10
The reference study challenges the established view that AMPK universally activates ULK1 during glucose starvation. Its experiments show that AMPK suppresses ULK1-dependent autophagy initiation during energy crisis while preserving the autophagy machinery for recovery after stress.
-
GS-441524: From Prodrug Assay to PK Insight
2026-08-09
Explore how GS-441524 supports mechanistic antiviral research, with a focus on prodrug conversion, matrix-aware LC–MS/MS design, and pharmacokinetic interpretation. This guide translates recent pathway-mapping findings into practical decisions for selecting analytes, controls, storage conditions, and assay readouts.
-
AM251 Workflows for CB1 Receptor Research
2026-08-08
AM251 gives researchers a pharmacological way to test whether CB1 signaling is required for neuronal, metabolic, or cellular phenotypes. This practical guide connects receptor-selective blockade with pain models, cAMP measurements, obesity treatment research, and apoptosis assays while emphasizing controls for solvent effects and sodium-channel activity.
-
Latrunculin A for Actin Dynamics Workflows
2026-08-07
Latrunculin A provides a rapid, reversible way to test whether actin assembly controls growth-cone behavior, cell shape, or motility. This guide translates stiffness-dependent DRG axon-regeneration findings into practical dosing, imaging, washout, and troubleshooting workflows.
-
CHI3L1-IN-5 (Compound Z17): Optimizing Neuroinflammation Ass
2026-08-07
CHI3L1-IN-5 (Compound Z17) stands out as a selective, CNS-penetrant inhibitor that enables researchers to dissect CHI3L1-mediated NF-κB signaling and astrocyte function with high specificity. Its unique mechanistic profile and favorable pharmacokinetics make it a robust tool for neurodegeneration models, with protocol-ready parameters to accelerate discovery.
-
Quercetin Inhibits Hippo Signaling to Protect Cataract Lense
2026-08-06
This study demonstrates that quercetin protects against cataract formation by suppressing the Hippo signaling pathway, which leads to reduced oxidative stress and promotes lens epithelial cell survival. The findings provide mechanistic insight into non-surgical cataract intervention and highlight the potential of targeted pathway modulation in lens disease.
-
Salvianolic acid B: Applied Protocols for Pulmonary Fibrosis
2026-08-06
Salvianolic acid B (Dan Shen Suan B) is redefining pulmonary fibrosis research by inhibiting lysyl hydroxylase 2 and disrupting pathological collagen cross-linking. This article decodes robust experimental workflows, advanced troubleshooting, and practical assay enhancements that leverage this natural product for extracellular matrix remodeling studies.
-
Adipose-Neural Axis in Cardiac Arrhythmia: Mechanistic Insig
2026-08-05
Fan et al. (2024) reveal how the interplay between epicardial adipose tissue and sympathetic neurons contributes to cardiac arrhythmia, highlighting leptin and neuropeptide Y signaling as key mediators. Their stem cell-based co-culture model uncovers intervention points with translational relevance for arrhythmia research.
-
Fucoidan as a Precision Modulator of Cancer Cell Plasticity
2026-08-05
Explore how Fucoidan, a sulfated α-L-fucan, uniquely targets cancer cell plasticity and apoptosis. This article provides advanced mechanistic insight and protocol guidance for oncology research, setting it apart from existing content.
-
Griseofulvin (SKU B3680): Reliable Microtubule Disruption in
2026-08-04
This article offers practical guidance for using Griseofulvin (SKU B3680) as a microtubule associated inhibitor in cell-based assays. Drawing on current literature and real-world laboratory scenarios, we address experimental design, data interpretation, and product selection—highlighting the reagent’s verified purity and workflow compatibility for reproducible antifungal and cytogenetic research.
-
CBD Modulates Orofacial Inflammatory Pain via Endocannabinoi
2026-08-04
This study demonstrates that cannabidiol (CBD) not only reduces orofacial inflammatory pain in mice but also ameliorates associated anxiety, depression, and cognitive deficits. Through integrated behavioral and mechanistic assays, the research uncovers distinct peripheral and central endocannabinoid mechanisms underlying CBD's effects, highlighting translational potential for comprehensive pain management.